Consistently, we found that the TTP KO mice treated with DSS displayed increased susceptibility to colitis, decreased colon length, and increased neutrophil infiltration and expression of pro-inflammatory cytokines such as TNF-α, IL-6, CXCL1, and CXCL2 in the large intestinal mucosa. The gene discussed is ZFP36; the disease is colitis.